noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

Company News

TikTok Inc.

TikTok LIVE Fest 2026: The Journey to the Global Stage Begins
TikTok Inc.

TikTok Launches First Creator Supper Club In Partnership With Marks &[...]
Universal Orlando Attract

Universal Orlando Resort Kicks Off Its Destination-Wide[...]

Pharmaceuticals and Biotechnology

IDL Diagnostics AB (publ)

11/11/2026 | Press release | Distributed by Public on 11/11/2026 08:32

Concile Global explores opportunities to expand its POCT portfolio

Nov 11, 2026

During a recent visit to KSB Biotech in China, IDL Diagnostics and its German partner concile explored potential additions to Concile Global's international point-of-care testing portfolio.

Discussions focused on biomarkers compatible with the reader platforms already used for UBC® Rapid, potentially enabling a broader offering through shared instruments and distribution channels. Opportunities remain under evaluation.

IDL Diagnostics AB (publ) published this content on November 11, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on November 11, 2026 at 14:32 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]

Back

View original format